Perceived helpfulness of bipolar disorder treatment: Findings from the World Health Organization World Mental Health Surveys

Autor(es):Mostrar menos -

Nierenberg, Andrew A. ^{[1, 2]} ; Harris, Meredith G. ^{[3, 4]} ; Kazdin, Alan E. ^[5] ; Puac-Polanco, Victor ^[6] ; Sampson, Nancy ^[6] ; Vigo, Daniel V. ^{[7, 8]} ; Chiu, Wai Tat ^[6] ; Ziobrowski, Hannah N. ^[6] ; Alonso, Jordi ^{[9, 10, 11]} ; Altwaijri, Yasmin ^[12] ; Borges, Guilherme ^[13] ; Bunting, Brendan ^[14] ; Caldas-de-Almeida, Jose Miguel ^{[15, 16]} ; Haro, Josep Maria ^{[17, 18]} ; Hu, Chi-yi ^{[19, 20]} ; Kiejna, Andrzej ^[21] ; Lee, Sing ^[22] ; McGrath, John J. ^{[23, 24, 3]} ; Navarro-Mateu, Fernando ^{[25, 26, 27]} ; Posada-Villa, Jose ^[28] ; Scott, Kate M. ^[29] ; Stagnaro, Juan C. ^[30] ; Viana, Maria C. ^[31] ; Kessler, Ronald C. ^[6] ; C, WHO World Mental Hlth Survey

Afiliação do(s) autor(es):Mostrar menos -

^[1] Massachusetts Gen Hosp, Dept Psychiat, Dauten Family Ctr Bipolar Treatment Innovat, Boston, MA 02114 - USA

^[2] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 - USA

^[3] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Wacol, Qld - Australia

^[4] Univ Queensland, Sch Publ Hlth, Herston, Qld - Australia

^[5] Yale Univ, Dept Psychol, New Haven, CT - USA

^[6] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 - USA

^[7] Univ British Columbia, Dept Psychiat, Vancouver, BC - Canada

^[8] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 - USA

^[9] Pompeu Fabra Univ UPF, Barcelona - Spain

^[10] CIBER Epidemiol & Salud Publ CIBERESP, Madrid - Spain

^[11] IMIM Hosp del Mar Med Res Inst, Hlth Serv Res Unit, Barcelona - Spain

^[12] King Faisal Specialist Hosp & Res Ctr, Epidemiol Sect, Riyadh - Saudi Arabia

^[13] Natl Inst Psychiat Ramon Fuente Muniz, Mexico City, DF - Mexico

^[14] Ulster Univ, Sch Psychol, Coleraine, Londonderry - North Ireland

^[15] Univ Nova Lisboa, Fac Ciencias Med, Chron Dis Res Ctr CEDOC, Lisbon - Portugal

^[16] Univ Nova Lisboa, Fac Ciencias Med, Lisbon Inst Global Mental Hlth, Lisbon - Portugal

^[17] King Saud Univ, Coll Educ, Dept Psychol, Riyadh - Saudi Arabia

^[18] Univ Barcelona, Parc Sanitari St Joan Deu, CIBERSAM, Barcelona - Spain

^[19] Shenzhen Inst Mental Hlth, Shenzhen - Peoples R China

^[20] Shenzhen Kangning Hosp, Shenzhen - Peoples R China

^[21] WSB Univ, Psychol Res Unit Publ Hlth, Torun - Poland

^[22] Chinese Univ Hong Kong, Dept Psychiat, Tai Po, Hong Kong - Peoples R China

^[23] Univ Queensland, Queensland Brain Inst, St Lucia, Qld - Australia

^[24] Aarhus Univ, Natl Ctr Register based Res, Aarhus - Denmark

^[25] IMIB Arrixaca, Murcia - Spain

^[26] Serv Murciano Salud, UDIF SM, Murcia - Spain

^[27] CIBERESP, Murcia - Spain

^[28] Colegio Mayor Cundinamarca Univ, Fac Social Sci, Bogota - Colombia

^[29] Univ Otago, Dept Psychol Med, Dunedin - New Zealand

^[30] Univ Buenos Aires, Fac Med, Dept Psiquiatria & Salud Mental, Buenos Aires, DF - Argentina

^[31] Univ Fed Espirito Santo, Postgrad Program Publ Hlth, Dept Social Med, Vitoria, ES - Brazil

• Tipo de documento: Artigo Científico
• Fonte: BIPOLAR DISORDERS; v. 23, n. 6, p. 565-583, SEP 2021.
• Citações Web of Science: 0

Resumo

Objectives To examine patterns and predictors of perceived treatment helpfulness for mania/hypomania and associated depression in the WHO World Mental Health Surveys. Methods Face-to-face interviews with community samples across 15 countries found n = 2,178 who received lifetime mania/hypomania treatment and n = 624 with lifetime mania/hypomania who received lifetime major depression treatment. These respondents were asked whether treatment was ever helpful and, if so, the number of professionals seen before receiving helpful treatment. Patterns and predictors of treatment helpfulness were examined separately for mania/hypomania and depression. Results 63.1% (mania/hypomania) and 65.1% (depression) of patients reported ever receiving helpful treatment. However, only 24.5-22.5% were helped by the first professional seen, which means that the others needed to persist in help seeking after initial unhelpful treatments in order to find helpful treatment. Projections find only 22.9% (mania/hypomania) and 43.3% (depression) would persist through a series of unhelpful treatments but that the proportion helped would increase substantially if persistence increased. Few patient-level significant predictors of helpful treatment emerged and none consistently either across the two components (i.e., provider-level helpfulness and persistence after earlier unhelpful treatment) or for both mania/hypomania and depression. Although prevalence of treatment was higher in high-income than low/middle-income countries, proportional helpfulness among treated cases was nearly identical in the two groups of countries. Conclusions Probability of patients with mania/hypomania and associated depression obtaining helpful treatment might increase substantially if persistence in help-seeking increased after initially unhelpful treatments, although this could require seeing numerous additional treatment providers. In addition to investigating reasons for initial treatments not being helpful, messages reinforcing the importance of persistence should be emphasized to patients. (AU)

• Processo FAPESP: 03/00204-3 - Estudo epidemiológico dos transtornos psiquiátricos na região metropolitana de São Paulo: prevalências, fatores de risco e sobrecarga social e econômica
• Beneficiário: Laura Helena Silveira Guerra de Andrade
• Modalidade de apoio: Auxílio à Pesquisa - Temático